FR2282899B1 - - Google Patents

Info

Publication number
FR2282899B1
FR2282899B1 FR7526651A FR7526651A FR2282899B1 FR 2282899 B1 FR2282899 B1 FR 2282899B1 FR 7526651 A FR7526651 A FR 7526651A FR 7526651 A FR7526651 A FR 7526651A FR 2282899 B1 FR2282899 B1 FR 2282899B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7526651A
Other languages
French (fr)
Other versions
FR2282899A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2282899A1 publication Critical patent/FR2282899A1/fr
Application granted granted Critical
Publication of FR2282899B1 publication Critical patent/FR2282899B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7526651A 1974-08-30 1975-08-29 Steroides de la serie de l'androstane, leur preparation et leurs applications Granted FR2282899A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38090/74A GB1514476A (en) 1974-08-30 1974-08-30 Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates

Publications (2)

Publication Number Publication Date
FR2282899A1 FR2282899A1 (fr) 1976-03-26
FR2282899B1 true FR2282899B1 (sv) 1978-11-10

Family

ID=10401112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7526651A Granted FR2282899A1 (fr) 1974-08-30 1975-08-29 Steroides de la serie de l'androstane, leur preparation et leurs applications

Country Status (11)

Country Link
JP (1) JPS5148649A (sv)
BE (1) BE832889A (sv)
CH (1) CH612686A5 (sv)
DE (1) DE2538595A1 (sv)
DK (1) DK136074B (sv)
FR (1) FR2282899A1 (sv)
GB (1) GB1514476A (sv)
IE (1) IE41663B1 (sv)
NL (1) NL7510226A (sv)
SE (1) SE405976B (sv)
ZA (1) ZA755553B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
CH614960A5 (sv) * 1976-04-15 1979-12-28 Ciba Geigy Ag
DE2809491A1 (de) * 1977-03-09 1978-09-14 Ciba Geigy Ag Anticoccidielle und ovo-larvicide mittel
SE452468B (sv) * 1980-02-15 1987-11-30 Glaxo Group Ltd Androstankarbotioater, forfarande for framstellning av dessa samt kompositioner
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
AU2003202044A1 (en) * 2002-01-15 2003-09-09 Glaxo Group Limited 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
WO2003062259A2 (en) * 2002-01-21 2003-07-31 Glaxo Group Limited Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
ITMI20020676A1 (it) * 2002-03-29 2003-09-29 Farmabios S R L Ora Farmabios Processo di preparazione di 6(alfa)-fluro steroidi
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
US7579335B2 (en) 2005-01-10 2009-08-25 Glaxo Group Limited Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids

Also Published As

Publication number Publication date
GB1514476A (en) 1978-06-14
JPS5148649A (sv) 1976-04-26
AU8440475A (en) 1977-03-03
DK136074C (sv) 1978-01-16
IE41663B1 (en) 1980-02-27
NL7510226A (nl) 1976-03-02
BE832889A (fr) 1976-03-01
DK389175A (sv) 1976-03-01
IE41663L (en) 1976-02-29
ZA755553B (en) 1976-09-29
CH612686A5 (en) 1979-08-15
FR2282899A1 (fr) 1976-03-26
DK136074B (da) 1977-08-08
DE2538595A1 (de) 1976-03-11
SE7509651L (sv) 1976-03-01
SE405976B (sv) 1979-01-15

Similar Documents

Publication Publication Date Title
FR2260764A1 (sv)
DK136075C (sv)
DK136074C (sv)
DK5575A (sv)
FR2270718A1 (sv)
FR2274624B1 (sv)
FR2264109A1 (sv)
FR2292903B1 (sv)
FR2269202B1 (sv)
AU495930B2 (sv)
FR2289511B1 (sv)
CH569220A5 (sv)
BG20854A1 (sv)
BG19847A1 (sv)
BG19987A1 (sv)
CH568539A5 (sv)
CH41675A4 (sv)
CH562462A5 (sv)
BG20885A1 (sv)
CH563933A5 (sv)
DD122377A5 (sv)
DD117156A1 (sv)
BG20446A1 (sv)
CH608512A5 (sv)
BG20451A1 (sv)

Legal Events

Date Code Title Description
ST Notification of lapse